Gottlieb calls for FDA reform, investment to counter Chinese medical innovation
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesGlobalGovernment/legislationLeadershipMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)